Tamoxifen induces p21(WAF1) and p27(KIP1) expression in estrogen receptor-negative lung cancer cells

Oncogene

Volumn 18, Issue 29, 1999, Pages 4269-4274

  Lee, Te Hsiu ^a   Chuang, Lea Yea ^a   Hung, Wen Chun ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Estrogen receptor; p21(WAF1); p27(KIP1); Tamoxifen

Indexed keywords

ANTIESTROGEN; ANTIMITOTIC AGENT; CYCLIN DEPENDENT KINASE; CYCLIN E; ESTROGEN RECEPTOR; PROTEIN P21; PROTEIN P27; RETINOBLASTOMA PROTEIN; TAMOXIFEN; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; CDKN1A PROTEIN, HUMAN; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLINE; MICROTUBULE ASSOCIATED PROTEIN; TUMOR PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; CELL CYCLE G1 PHASE; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LUNG CANCER; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TRANSACTIVATION; TUMOR SUPPRESSOR GENE; BIOSYNTHESIS; CELL CULTURE; CELL DIVISION; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; LUNG NON SMALL CELL CANCER; LUNG TUMOR; METABOLISM; PATHOLOGY; STIMULATION;

ANTINEOPLASTIC AGENTS, HORMONAL; CARCINOMA, NON-SMALL-CELL LUNG; CELL CYCLE PROTEINS; CELL DIVISION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLINS; G1 PHASE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; RECEPTORS, ESTROGEN; RETINOBLASTOMA PROTEIN; STIMULATION, CHEMICAL; TAMOXIFEN; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0033595027     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1202755     Document Type: Article

References (50)

1. Amon A, Tyers M, Futcher B and Nasmyth D. (1993). Cell, 74, 993-1007.
2. Bates S and Vousden KH. (1996). Curr. Opin. Genet. Dev., 6, 12-18.
3. Bennett W, El-Deiry WS, Rush WL, Guinee DG, Freedman AN, Caporaso NE, Welsh JA, Jones RT, Borkowski A, Travis WD, Fleming MV, Trastek V, Pairolero PC, Tazelaar HD, Midthun D, Jett JR, Liotta LA and Harris CC. (1998). Clin. Cancer Res., 4, 1499-1506.
4. Cabot MC, Giuliano AE, Volner A and Han TY. (1996). FEBS Lett., 394, 129-131.
5. Caputi M, Esposito V, Baldi A, Luca AD, Dean C, Signoriello G, Baldi F and Giodano A. (1998). Am. J. Respir. Cell Mol. Biol., 18, 213-217.
6. Chiba I, Takahashi T, Nau MM, D'Amico D, Curiel DT, Mitsudomi T, Bucchagen DL, Carbone D, Piantadosi S, Koga H, Reissman PT, Slamon DJ, Holmes EC and Minna JD. (1990). Oncogene, 5, 1603-1610.
7. Couldwell WT, Weiss MH, DeGiorgia CM, Weiner LP, Hinton DR, Ehresmann GR, Conti PS and Apuzzo ML. (1993). Neurosurgery, 32, 485-489.
8. Cover CM, Hsieh SJ, Tran SH, Hallden G, Kim GS, Bjeldanes LF and Firestone GL. (1998). J. Biol. Chem., 273, 3838-3847.
9. Croxtall JD, Emmas C, White JO, Choudhary Q and Flower RJ. (1994). Biochem. Pharmacol., 47, 197-202.
10. DelPrete SA, Maurer LH, O'Donnel J, Forcier JR and LeMarbre P. (1984). Cancer Treat. Rep., 68, 1403-1405.
11. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW and Vogelslein B. (1993). Cell, 75, 817-825.
12. Enmark E, Pelto-Huikko M, Grandien K, Lagererantz S, Lagercrantz J, Fried G, Nordenskjold M and Gustafsson J. (1997). J. Clin. Endocrinol. Metab., 82, 4258-4265.
13. Furr BJA and Jordan VC. (1984). Pharmacol. Ther., 25, 127-205.
14. Guadagno TM and Newport JW. (1996). Cell, 84, 73-82.
15. Henderson BE, Ross RK and Pike MC. (1992). Science, 259, 633-638.
16. Hengst L and Reed SI. (1996). Science, 2271, 1861-1864.
17. Hirai H, Roussel MF, Kato JY, Ashmun RA and Sherr CJ. (1995). Mol. Cell. Biol., 15, 2672-2681.
18. Hung WC, Chai CY, Huang JS and Chuang LY. (1996a). Hum. Pathol., 27, 1324-1328.
19. Hung WC, Huang JS and Chuang LY. (1996b). Biochem. Biophys. Res. Commun. 220, 719-723.
20. Jordan VC and Murphy CS. (1990). Endocrin. Rev., 11, 578-610.
21. Jordan VC, Lababidi MK and Fakhey SL. (1991). J. Natl. Cancer Inst., 83, 492-496.
22. Jordan VC. (1994). Breast Cancer Res. Treat., 31, 41-52.
23. Knabbe C, Lippman ME, Wakefield LM, Flanders KC, Kasid A, Derynck R and Dickson RB. (1987). Cell, 48, 417-428.
24. Kiss Z. (1994). FEBS Lett., 355, 173-177.
25. Komiya T, Hosono Y, Hirashima T, Masuda N, Yasumitsu T, Nakagawa K, Kikui M, Ohno A, Fukuoka M and Kawase I. (1997). Clin. Cancer Res., 3, 1831-1835.
26. Kuiper GGJM, Enmark E, Pelto-Huikko M, Nisson S and Gustafsson JA. (1996). Proc. Natl. Acad. Sci. USA, 93, 5925-5930.
27. Kyle E, Neckers L, Takimoto C, Curt G and Bergan RC. (1997). Mol. Pharmacol. 51, 193-200.
28. Lew DJ and Kornbluth S. (1996). Curr. Opin. Cell Biol., 8, 795-804.
29. Liu M, Lee MH, Cohen M, Bommakanti M and Freedman LP. (1996). Genes Dev., 10, 142-153.
30. McClay E, McClay ME, Jones J, Winski P, Christen R, Howell S and Hall PA. (1997). Cancer, 79, 1037-1043.
31. Minami S, Ohtani-Fujita N, Igata E, Tamaki T and Sakai T. (1997). FEBS Lett., 411, 1-6.
32. Mitsudomi T, Steinberg SM, Nau MM, Carbone D, D'Amico D, Borner S, Oie HK, Linnoila I, Mulshine JL, Minna JD and Gazdar AF. (1992). Oncogene, 7, 171-180.
33. Mosmann T. (1983). J. Immunol. Meth., 65, 55-63.
34. O'Brian CA, Liskkamp RM, Soloman DH and Weinstein IB. (1986). J. Natl. Cancer Inst., 76, 1243-1246.
35. Pagano M, Tam SW, Theoforas AM, Beer-Romero P, Sal GD, Chau V, Yew PR, Draetta GF and Rolfe M. (1995). Science, 269, 682-685.
36. Pines J. (1993). Trends Biochem. Sci., 18, 195-197.
37. Planas-Silva MD and Weinberg RA. (1997). Mol. Cell. Biol., 17, 4059-4069.
38. Poluha W, Poulha DK, Chang B, Crosbie NE, Schonhoff CM, Kilpatrick DL and Ross AH. (1996). Mol. Cell. Biol., 16, 1335-1341.
39. Polyak K, Lee MH, Erdjument BH, Koff A, Roberts JM, Tempst P and Massague J. (1994). Cell, 78, 59-66.
40. Robinson EK, Grau AM, Evans DB, Smid CM, Chiao PJ, Abbruzzese JL and Grimm EA. (1998). Ann. Surg. Oncol., 5, 342-349.
41. Rohlff C, Blagoskonny MV, Kyle E, Kesari A, Kim IY, Zelner DJ, Hakim F, Trepel J and Bergan RC. (1998). Prostate, 37, 51-59.
42. Rowlands MG, Parr IB, McCaque R, Jarman M and Goddard PM. (1990). Biochem. Pharmacol., 40, 283-289.
43. Serrano M, Hannon GJ and Beach D. (1993). Nature, 366, 704-707.
44. Sutherland RL, Reddel RR and Green MD. (1983). Eur. J. Clin. Oncol., 19, 307-318.
45. Takahashi T, Nau MM, Chiba I, Birrer MJ, Rosenberg RK, Vinocour M, Levitt M, Pass H, Gazdar AF and Minna JD. (1989). Science, 246, 491-494.
46. Teixeira C and Pratt MAC. (1997). Mol. Endocrinol., 11, 1191-1202.
47. Tremblay GB, Tremblay A, Copeland NG, Gilbert DJ, Jenkins NA, Labrie F and Giguere V. (1997). Endocrinol., 11, 353-365.
48. Trump DL, Smith DC, Ellis PG, Rogers MP, Schold SC, Winer EP, Panella TJ, Jordan VC and Fine RL. (1992). J. Natl. Cancer Inst., 84, 1811-1816.
49. van den Heuvel and Harlow E. (1993). Science, 262, 2050-2054.
50. Yatabe Y, Masuda A, Koshikawa T, Nakamura S, Kuroishi T, Osada H, Takahashi T, Mitsudomi T and Takahashi T. (1998). Cancer Res., 58, 1042-1047.